Source – Pregabalin prescribing patterns in Australian general practice, 2012–2018: a cross-sectional study[/caption]
National Medicines Symposium 2024 speakers (L to R): Steve Waller, Professor Jennifer Martin, Professor Libby Roughead, Tegan Taylor[/caption]
This CPD activity is sponsored by Reckitt. All content is the true, accurate and independent opinion of the speakers and the views expressed are entirely their own.[/caption]
Exenatide for alcohol use disorder
A better understanding of exenatide can help increase our knowledge of GLP-1 analogues and their possible role in treating addiction.
A good night’s sleep
References
1. Hillman D, Mitchell S, Streatfeild J, et al. The economic cost of inadequate sleep. Sleep 2018;41(8). Epub 2018 Jun 4.
2. Claughton D. Farmers...
Long-acting treatment for opioid dependence approved
The first long-acting treatment for opioid dependence has been approved for use in Australia by the Therapeutic Goods Administration (TGA).
Buvidal Weekly and Buvidal Monthly...
Protecting your over 60s from the flu
Get ready to help to protect vulnerable Australians over the age of 60 years from influenza and its most deadly complications.
Waiting to inhale
Annoyed by her glass squeeze-bulb nebuliser, 13-year old asthmatic Susie Maison asked "Daddy why can't they put my asthma medicine in a spray can?"
